A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents

[1]  P Vaupel,et al.  Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. , 1991, Cancer research.

[2]  P. Vaupel,et al.  Tumor tissue oxygenation as evaluated by computerized-pO2-histography. , 1990, International journal of radiation oncology, biology, physics.

[3]  T S Herman,et al.  Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma. , 1990, Cancer research.

[4]  P Vaupel,et al.  Oxygenation of human tumors. , 1990, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[5]  B. Teicher,et al.  Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma. , 1990, Cancer Research.

[6]  G. Adams.  The clinical relevance of tumour hypoxia. , 1990, European journal of cancer.

[7]  B. Teicher,et al.  Evidence for enzymatic activation and oxygen involvement in cytotoxicity and antitumor activity of N,N',N''-triethylenethiophosphoramide. , 1989, Cancer research.

[8]  P. Okunieff,et al.  Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. , 1989, Cancer research.

[9]  B. Teicher,et al.  Optimization of perfluorochemical levels with radiation therapy in mice. , 1989, Cancer research.

[10]  B. Teicher,et al.  Effect of Fluosol-DA on the response of intracranial 9L tumors to X rays and BCNU. , 1988, International journal of radiation oncology, biology, physics.

[11]  P Vaupel,et al.  Evaluation of oxygen diffusion distances in human breast cancer xenografts using tumor-specific in vivo data: role of various mechanisms in the development of tumor hypoxia. , 1988, International journal of radiation oncology, biology, physics.

[12]  B. Teicher,et al.  Effect of various oxygenation conditions and fluosol-DA on cytotoxicity and antitumor activity of bleomycin in mice. , 1988, Journal of the National Cancer Institute.

[13]  B. Teicher,et al.  The effect of fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo , 1988, Cancer Chemotherapy and Pharmacology.

[14]  B. Teicher,et al.  Effects of fluosol‐DA and oxygen breathing on adriamycin antitumor activity and cardiac toxicity in mice , 1988, Cancer.

[15]  A. Sartorelli.  Therapeutic attack of hypoxic cells of solid tumors: presidential address. , 1988, Cancer research.

[16]  B. Teicher,et al.  Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity. , 1987, Cancer research.

[17]  Teicher Ba,et al.  Survey of the effect of adding Fluosol-DA 20%/O2 to treatment with various chemotherapeutic agents. , 1987 .

[18]  B. Teicher,et al.  Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity. , 1987, Cancer research.

[19]  B. Teicher,et al.  Effect of Fluosol‐DA/O2 on tumor‐cell and bone‐marrow cytotoxicity of nitrosoureas in mice bearing FSA‐II fibrosarcoma , 1986, International journal of cancer.

[20]  B. Teicher,et al.  Differential enhancement of melphalan cytotoxicity in tumor and normal tissue by fluosol‐DA® and oxygen breathing , 1985, International journal of cancer.

[21]  J. Fowler.  Eighth annual Juan del Regato lecture. Chemical modifiers of radiosensitivity--theory and reality: a review. , 1985, International journal of radiation oncology, biology, physics.

[22]  B. Teicher,et al.  Perfluorochemical emulsions can increase tumor radiosensitivity. , 1984, Science.

[23]  J. Riess,et al.  Reassessment of criteria for the selection of perfluorochemicals for second-generation blood substitutes: analysis of structure/property relationships. , 1984, Artificial organs.

[24]  J. G. Riess,et al.  Solubility and transport phenomena in perfluorochemicals relevant to blood substitution and other biomedical applications , 1982 .

[25]  H. Suit,et al.  The radiosensitivity of a murine fibrosarcoma as measured by three cell survival assays. , 1980, The British journal of cancer. Supplement.

[26]  B. Teicher,et al.  Effect of Fluosol-DA/O2 on the antitumor activity and pulmonary toxicity of bleomycin , 2004, Cancer Chemotherapy and Pharmacology.

[27]  G. Kim,et al.  The influence of Fluosol-DA and carbogen breathing on the antitumor effects of cyclophosphamide in vivo , 2004, Cancer Chemotherapy and Pharmacology.

[28]  B. Teicher,et al.  Rate of infusion: an important factor in circulatory effects of perfluorochemical emulsions (PFCES). , 1990 .

[29]  B. Teicher,et al.  Effect of various oxygenation conditions and fluosol-DA on cancer chemotherapeutic agents. , 1988, Biomaterials, artificial cells, and artificial organs.

[30]  B. Teicher,et al.  Survey of the effect of adding Fluosol-DA 20%/O2 to treatment with various chemotherapeutic agents. , 1987, Cancer treatment reports.

[31]  B. Teicher,et al.  Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. , 1981, Cancer research.

[32]  B. Teicher,et al.  The hypoxic tumor cell: a target for selective cancer chemotherapy. , 1980, Biochemical pharmacology.